Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery

Robert C G Martin, Alan North Durham, Marc G. Besselink, David Iannitti, Matthew J Weiss, Christopher Wolfgang, Kai Wen Huang

Research output: Contribution to journalArticlepeer-review

Abstract

Irreversible Electroporation (IRE) is used to treat locally advanced cancers, commonly of the pancreas, liver, kidney, and other soft tissues. Precise eligibility for IRE should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of IRE technique and protocols is expected to improve safety, lead to reproducible outcomes, and facilitate further research into IRE. The present article provides a set of technical recommendations for the use of IRE in the treatment of locally advanced pancreatic cancer. J. Surg. Oncol. 2016;114:865–871.

Original languageEnglish (US)
Pages (from-to)865-871
Number of pages7
JournalJournal of Surgical Oncology
Volume114
Issue number7
DOIs
StatePublished - Dec 1 2016

Keywords

  • irreversible electroporation
  • pancreatic cancer
  • technique

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery'. Together they form a unique fingerprint.

Cite this